Kanabo Group Plc (LON:KNB)
London · Delayed Price · Currency is GBP · Price in GBX 0.2250
-0.0750 (-25.00%)
Apr 30, 2025, 4:20 PM BST
Kanabo Group Company Description
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.
It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.
It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products.
Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.
Kanabo Group Plc
| Country | United Kingdom |
| Founded | 2016 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Avihu Tamir |
Contact Details
Address: Churchill House London, NW4 4DJ United Kingdom | |
| Website | kanabogroup.com |
Stock Details
| Ticker Symbol | KNB |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB00BYQCS703 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Avihu Tamir | Chief Executive Officer, Executive Director and Secretary |
| David Sack | Co-founder |
| Assaf Vardimon | Chief Financial Officer |
| Suleman Sacranie | Chief Technology Officer |